Search Results - Haderselv, K

  • Showing 1 - 2 results of 2
Refine Results
  1. 1
    P347 Vedolizumab as first line biologic therapy in elderly patients with contraindications against anti-TNF therapy - A real-world nationwide cohort of patients with inflammatory bowel diseases

    P347 Vedolizumab as first line biologic therapy in elderly patients with contraindications against anti-TNF therapy - A real-world nationwide cohort of patients with inflammatory b... by Attauabi, M, Höglund, C, Fassov, J, Pedersen, K B, Bansholm Hansen, H, Wildt, S, Dam Jensen, M, Neumann, A, Lind, C, Albæk Jacobsen, H, Popa, A M, Kjeldsen, J, Pedersen, N, Molazahi, A, Haderselv, K, Aalykke, C, Knudsen, T, Cebula, W, Munkholm, P, Bendtsen, F, Seidelin, J B, Johan, B

    Get full text
    Article
    Save to List
    Saved in:
  2. 2
    P102 Outcomes of coronavirus disease 2019 among patients with inflammatory bowel diseases and the influence of IBD-related medications– A Danish prospective population-based cohort study

    P102 Outcomes of coronavirus disease 2019 among patients with inflammatory bowel diseases and the influence of IBD-related medications– A Danish prospective population-based cohort... by Attauabi, M, Poulsen, A, Kajbæk Verner-Andersen, M, Rosager Hansen, M, Pedersen, N, Pilegaard Prahm, A, Berg Lødrup, A, Haderselv, K, Larsen, L, Jess, T, Glerup, H, Molazahi, A, Mathiassen Oppfeldt, A, Dahlerup, J F, Lodberg Hvas, C, Neumann, A, Wase, A, Dam Jensen, M, Nathan, T, Jensen, S, Theede, K, Kiszka-Kanowitz, M, Benedict Seidelin, J, Burisch, J

    Get full text
    Article
    Save to List
    Saved in:

Search Tools: